Aedifica Value Stock - Dividend - Research Selection
Market price: 101,60 EUR
Aedifica Fundamental data and company key figures of the share
|Annual reports in EUR|
|Net operating cash flow||70.284.000|
|Free cash flow||70.222.000|
|Liabilities & Shareholders equity||2.386.130.000|
|Diluted shares outstanding||19.266.300|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||2.249.690.880,00 USD|
|Indices||STOXX EUROPE 600|
|Raw Data Source||IFRS in Millionen EUR|
|Stock Split||2019-04-25,1487.000000/1413.000000; 2017-03-16,766.000000/745.000000; 2015-06-11,165.000000/161.000000; 2012-11-19,582.000000/551.000000; 2010-09-23,974.000000/915.000000|
Description of the company
Aedifica is a Regulated Real Estate Company under Belgian law specialised in European healthcare real estate, particularly in senior housing. Aedifica has developed a portfolio of more than 270 sites in Belgium, Germany, the Netherlands and the United Kingdom, worth more than 2.4 billion. In November, the Group launched a tender offer on the shares of Hoivatilat, the Finnish healthcare real estate investor with which Aedifica wants to enter the Nordics. Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019) and is identified by the following ticker symbols: AED; AED:BB (Bloomberg); AOO.BR (Reuters). The Company's market capitalisation was approx. 2.7 billion as of 12 November 2019. Aedifica is included in the EPRA indices.